Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis

The present invention relates to organometallic compounds useful in the treatment of metastasis. The organometallic compounds comprise a ligand that is convalently bound to a bioactive compound, which is an inhibitor of a resistance pathway or a derivative thereof. Preferably, the organometallic compounds are half-sandwich ("piano-stool") compounds. The compounds of the present invention offer a high variability with respect to the bioactive compound and to the nature of the ligand bound to a central transition metal.


Year:
2007
Other identifiers:
TTO: 6.0662
EPO Family ID: 37770371
Laboratories:




 Record created 2015-09-22, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)